He LN, Fu S, Zhang X, Hu Q, et al. Baseline and early changes in circulating Serum Amyloid A (SAA) predict survival outcomes in advanced non-small cell lung cancer patients treated with Anti-PD-1/PD-L1 monotherapy. Lung Cancer 2021;158:1-8.
PMID: 34087538